Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | Methoxyacetic Acid | HCID 12251 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | (E)-2(R)-[1(S)-[(tetrahydro-2(RS)-pyranyloxy)-carbamoyl]-4-phenyl-3-butenyl]-2'-isobutyl-4-methylvalerohydrazide | HCID 86756879 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 91594889 | HCID 91594889 | — |
Reaction Steps
A solution of 0.180 g of methoxyacetic acid in 10 ml of dimethylformamide was treated in sequence with 0.254 ml of N-ethylmorpholine, 0.270 g of 1-hydroxybenzotriazole and 0.384 g of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride. Stirring was continued at room temperature for 1 hour and then 0.459 g of (E)-2(R)-[1(S)-[(tetrahydro-2(RS)-pyranyloxy)carbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-4-methylvalerohydrazide was added. Stirring was continued at room temperature overnight and then the solvent was evaporated and replaced by ethyl acetate. The ethyl acetate layer was washed with 5% aqueous citric acid, 5% aqueous sodium hydrogen carbonate and brine and then dried over anhydrous magnesium sulphate. Evaporation and trituration with diethyl ether gave 0.543 g of (E)-2(R)-[1(S)-(tetrahydro-2(RS)-pyranyloxy)carbamoyl]-4-phenyl-3-butenyl]-2′-isobutyl-2′-(2-methoxyacetyl)-4-methylvalerohydrazide in the form of a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06239151B1 |
|---|
| Source dataset | uspto-grants-2001_05 |
|---|
| ORD ID | ord-6709474b15214f5792e42e8f32e5793b |
|---|
| Source note | uspto-grants-2001_05 |
|---|